| Literature DB >> 25851998 |
Gareth Baynam1,2,3,4,5, Angela Overkov1, Mark Davis6,7, Kym Mina6,7, Lyn Schofield1,4, Richard Allcock6,7, Nigel Laing8, Matthew Cook9,10, Hugh Dawkins2,6,11,12, Jack Goldblatt1,2,3.
Abstract
We report on three Aboriginal Australian siblings with a unique phenotype which overlaps with known megalencephaly syndromes and RASopathies, including Costello syndrome. A gain-of-function mutation in MTOR was identified and represents the first reported human condition due to a germline, familial MTOR mutation. We describe the findings in this family to highlight that (i) the path to determination of pathogenicity was confounded by the lack of genomic reference data for Australian Aboriginals and that (ii) the disease biology, functional analyses in this family, and studies on the tuberous sclerosis complex support consideration of an mTOR inhibitor as a therapeutic agent.Entities:
Keywords: Aboriginal; RASopathy; indigenous; mTOR; megalencephaly; rapamycin; repurposing
Mesh:
Substances:
Year: 2015 PMID: 25851998 DOI: 10.1002/ajmg.a.37070
Source DB: PubMed Journal: Am J Med Genet A ISSN: 1552-4825 Impact factor: 2.802